DRH Q1 2026 Earnings Strong EPS Beat Amidst Operational Discipline VAC Q1 2026 Earnings EPS Falls Short of Expectations SPG Q1 2026 Earnings Modest EPS Miss Amid Stable Operational Performance SOBR Q3 2025 Earnings Negative EPS Reported No Revenue Disclosed Dermata Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss Supports Ongoing Clinical Development NATR Q1 2026 Earnings Strong EPS Beat Drives Profitability Focus Amid Modest Market Response